Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation

References

• Vose JM, Chiu BC, Cheson BD, Dancey J, Wright J. Update on epidemiology and therapeutics for non-Hodgkin's lymphoma. Hematology Am Soc Hematol Educ Program 2002; 1:241-62; PMID:12446426; http://dx.doi.org/10.1182/asheducation-2002.1.241
   PubMedGoogle Scholar
• Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010; 12:814-22; PMID:20811353; http://dx.doi.org/10.1038/ncb0910-814
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Thorburn A. Clinical research and Autophagy. Autophagy 2014; 10:1357-8; PMID:24991837; http://dx.doi.org/10.4161/auto.29159
   PubMed Web of Science ®Google Scholar
• Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009; 20:1981-91; PMID:19211835; http://dx.doi.org/10.1091/mbc.E08-12-1248
   PubMed Web of Science ®Google Scholar
• Schrump DS. Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications. Clin Cancer Res 2009; 15:3947-57; PMID:19509170; http://dx.doi.org/10.1158/1078-0432.CCR-08-2787
   PubMed Web of Science ®Google Scholar
• Banreti A, Sass M, Graba Y. The emerging role of acetylation in the regulation of autophagy. Autophagy 2013; 9:819-29; PMID:23466676; http://dx.doi.org/10.4161/auto.23908
   PubMed Web of Science ®Google Scholar
• Brodie SA, Brandes JC. Could valproic acid be an effective anticancer agent? The evidence so far. Exp Rev Anticancer Ther 2014; 14:1097-100; PMID:25017212; http://dx.doi.org/10.1586/14737140.2014.940329
   PubMed Web of Science ®Google Scholar
• Dong LH, Cheng S, Zheng Z, Wang L, Shen Y, Shen ZX, Chen SJ, Zhao WL. Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma. J Hematol Oncol 2013; 6:53; PMID:23866964; http://dx.doi.org/10.1186/1756-8722-6-53
   PubMed Web of Science ®Google Scholar
• Mack HI, Zheng B, Asara JM, Thomas SM. AMPK-dependent phosphorylation of ULK1 regulates ATG9 localization. Autophagy 2012; 8:1197-214; PMID:22932492; http://dx.doi.org/10.4161/auto.20586
   PubMed Web of Science ®Google Scholar
• Cardenas C, Miller RA, Smith I, Bui T, Molgo J, Muller M, Vais H, Cheung KH, Yang J, Parker I, et al. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 2010; 142:270-83; PMID:20655468; http://dx.doi.org/10.1016/j.cell.2010.06.007
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8:445-544; PMID:22966490; http://dx.doi.org/10.4161/auto.19496
   PubMed Web of Science ®Google Scholar
• Meijer AJ, Codogno P. Autophagy: regulation by energy sensing. Curr Biol 2011; 21: R227-9; PMID:21419990; http://dx.doi.org/10.1016/j.cub.2011.02.007
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13:132-41; PMID:21258367; http://dx.doi.org/10.1038/ncb2152
   PubMed Web of Science ®Google Scholar
• Williams RS, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature 2002; 417:292-5; PMID:12015604; http://dx.doi.org/10.1038/417292a
   PubMed Web of Science ®Google Scholar
• Levine B. Unraveling the role of autophagy in cancer. Autophagy 2006; 2:65-6; PMID:16874090 http://dx.doi.org/10.4161/auto.2.2.2457
   PubMed Web of Science ®Google Scholar
• Kondo Y, Kondo S. Autophagy and cancer therapy. Autophagy 2006; 2:85-90; PMID:16874083 http://dx.doi.org/10.4161/auto.2.2.2463
   PubMed Web of Science ®Google Scholar
• Shimizu R, Kikuchi J, Wada T, Ozawa K, Kano Y, Furukawa Y. HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells. Leukemia 2010; 24:1760-8; PMID:20686505; http://dx.doi.org/10.1038/leu.2010.157
   PubMed Web of Science ®Google Scholar
• Scherpereel A, Berghmans T, Lafitte JJ, Colinet B, Richez M, Bonduelle Y, Meert AP, Dhalluin X, Leclercq N, Paesmans M, et al. Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study. Eur Respir J 2011; 37:129-35; PMID:20530048; http://dx.doi.org/10.1183/09031936.00037310
   PubMed Web of Science ®Google Scholar
• Cimino G, Lo-Coco F, Fenu S, Travaglini L, Finolezzi E, Mancini M, Nanni M, Careddu A, Fazi F, Padula F, et al. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia. Cancer Res 2006; 66:8903-11; PMID:16951208; http://dx.doi.org/10.1158/0008-5472.CAN-05-2726
   PubMed Web of Science ®Google Scholar
• Munster P, Marchion D, Bicaku E, Lacevic M, Kim J, Centeno B, Daud A, Neuger A, Minton S, Sullivan D. Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I/II trial of valproic acid and epirubicin/FEC. Clin Cancer Res 2009; 15:2488-96; PMID:19318486; http://dx.doi.org/10.1158/1078-0432.CCR-08-1930
   PubMed Web of Science ®Google Scholar
• Fu J, Shao CJ, Chen FR, Ng HK, Chen ZP. Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. Neuro-oncology 2010; 12:328-40; PMID:20308311; http://dx.doi.org/10.1093/neuonc/nop005
   PubMed Web of Science ®Google Scholar
• Ouyang DY, Xu LH, He XH, Zhang YT, Zeng LH, Cai JY, Ren S. Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5. Autophagy 2013; 9:20-32; PMID:23075929; http://dx.doi.org/10.4161/auto.22397
   PubMed Web of Science ®Google Scholar
• Botrugno OA, Robert T, Vanoli F, Foiani M, Minucci S. Molecular pathways: old drugs define new pathways: non-histone acetylation at the crossroads of the DNA damage response and autophagy. Clin Cancer Res 2012; 18:2436-42; PMID:22512979; http://dx.doi.org/10.1158/1078-0432.CCR-11-0767
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 2012; 11:709-30; PMID:22935804; http://dx.doi.org/10.1038/nrd3802
   PubMed Web of Science ®Google Scholar
• Akl H, Bultynck G. Altered Ca2+ signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors. Biochimica et biophysica acta 2013; 1835:180-93; PMID:23232185; http://dx.doi.org/10.1016/j.bbcan.2012.12.001
   PubMed Web of Science ®Google Scholar
• Zhong F, Harr MW, Bultynck G, Monaco G, Parys JB, De Smedt H, Rong YP, Molitoris JK, Lam M, Ryder C, et al. Induction of Ca2+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction. Blood 2011; 117:2924-34; PMID:21193695; http://dx.doi.org/10.1182/blood-2010-09-307405
   PubMed Web of Science ®Google Scholar
• Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 2005; 170:1101-11; PMID:16186256; http://dx.doi.org/10.1083/jcb.200504035
   PubMed Web of Science ®Google Scholar
• Rasola A, Bernardi P. The mitochondrial permeability transition pore and its adaptive responses in tumor cells. Cell Calcium 2014; 56:437-45; PMID:25454774; http://dx.doi.org/10.1016/j.ceca.2014.10.003
   PubMed Web of Science ®Google Scholar
• Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 2010; 9:447-64; PMID:20467424; http://dx.doi.org/10.1038/nrd3137
   PubMed Web of Science ®Google Scholar
• Kondratskyi A, Yassine M, Kondratska K, Skryma R, Slomianny C, Prevarskaya N. Calcium-permeable ion channels in control of autophagy and cancer. Front Physiol 2013; 4:272; PMID:24106480; http://dx.doi.org/10.3389/fphys.2013.00272
   PubMed Web of Science ®Google Scholar
• Szatkowski C, Parys JB, Ouadid-Ahidouch H, Matifat F. Inositol 1,4,5-trisphosphate-induced Ca2+ signalling is involved in estradiol-induced breast cancer epithelial cell growth. Mol Cancer 2010; 9:156; PMID:20565939; http://dx.doi.org/10.1186/1476-4598-9-156
   PubMed Web of Science ®Google Scholar
• Bonora M, Pinton P. The Mitochondrial Permeability Transition Pore and Cancer: Molecular Mechanisms Involved in Cell Death. Front Oncol 2014; 4:302; PMID:25478322; http://dx.doi.org/10.3389/fonc.2014.00302
   PubMedGoogle Scholar
• Zunino SJ, Storms DH. Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore. Cancer Lett 2006; 240:123-34; PMID:16226372; http://dx.doi.org/10.1016/j.canlet.2005.09.001
   PubMed Web of Science ®Google Scholar
• Clemencon B, Babot M, Trezeguet V. The mitochondrial ADP/ATP carrier (SLC25 family): pathological implications of its dysfunction. Mol Aspects Med 2013; 34:485-93; PMID:23506884; http://dx.doi.org/10.1016/j.mam.2012.05.006
   PubMed Web of Science ®Google Scholar
• Gallerne C, Touat Z, Chen ZX, Martel C, Mayola E, Sharaf el dein O, Buron N, Le Bras M, Jacotot E, Borgne-Sanchez A, et al. The fourth isoform of the adenine nucleotide translocator inhibits mitochondrial apoptosis in cancer cells. Int J Biochem Cell Biol 2010; 42:623-9; PMID:20060930; http://dx.doi.org/10.1016/j.biocel.2009.12.024
   PubMed Web of Science ®Google Scholar
• Shoshan-Barmatz V, Ben-Hail D, Admoni L, Krelin Y, Tripathi SS. The mitochondrial voltage-dependent anion channel 1 in tumor cells. Biochimica et biophysica acta 2014; Nov 4. pii: S0005-2736(14)00375-7. PMID:25448878; http://dx.doi.org/10.1016/j.bbamem.2014.10.040
   PubMed Web of Science ®Google Scholar
• Jiang N, Kham SK, Koh GS, Suang Lim JY, Ariffin H, Chew FT, Yeoh AE. Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL). J Proteomics 2011; 74:843-57; PMID:21396490; http://dx.doi.org/10.1016/j.jprot.2011.02.034
   PubMed Web of Science ®Google Scholar
• Suh DH, Kim MK, Kim HS, Chung HH, Song YS. Mitochondrial permeability transition pore as a selective target for anti-cancer therapy. Front Oncol 2013; 3:41; PMID:23483560; http://dx.doi.org/10.3389/fonc.2013.00041
   PubMedGoogle Scholar
• Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006; 58:621-81; PMID:16968952; http://dx.doi.org/10.1124/pr.58.3.10
   PubMed Web of Science ®Google Scholar